Related Experiment Video
Updated: Feb 27, 2026

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
Published on: April 28, 2015
Biodegradable nanoparticles for improved kidney bioavailability of rhein: preparation, characterization, plasma, and
Yinghui Wei1, Xiaoting Luo1, Jiani Guan1
1a College of Pharmaceutical Science, Zhejiang Chinese Medical University , Hangzhou , China.
Abstract:
The aim of this work is to develop biodegradable nanoparticles for improved kidney bioavailability of rhein (RH). RH-loaded nanoparticles were prepared using an emulsification solvent evaporation method and fully characterized by several techniques. Kidney pharmacokinetics was assessed by implanting a microdialysis probe in rat's kidney cortex. Blood samples were simultaneously collected (via femoral artery) for assessing plasma pharmacokinetics. Optimized nanoparticles were small, with a mean particle size of 132.6 ± 5.95 nm, and homogeneously dispersed. The charge on the particles was nearly zero, the encapsulation efficiency was 62.71 ± 3.02%, and the drug loading was 1.56 ± 0.15%. In vitro release of RH from the nanoparticles showed an initial burst release followed by a sustained release. Plasma and kidney pharmacokinetics showed that encapsulation of RH into nanoparticles significantly increased its kidney bioavailability (AUCkidney/AUCplasma = 0.586 ± 0.072), clearly indicating that nanoparticles are a promising strategy for kidney drug delivery.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioavailability: Influencing Factors
Bioavailability Enhancement: Drug Solubility Enhancement
Measurement of Bioavailability: Pharmacokinetic Methods
Modified-Release Drug Delivery Systems: Bioavailability
Renal Drug Excretion: Tubular Secretion

